Bank of New York Mellon
AFIB

Bank of New York Mellon’s Acutus Medical Inc AFIB Stock Holding History

Bank of New York Mellon’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,680
Closed -$12K – 4611
2022
Q2 		$12K Sell
10,680
-49,298
-82% -$42.3K ﹤0.01% 4540
2022
Q1 		$83K Sell
59,978
-8,423
-12% -$18K ﹤0.01% 4439
2021
Q4 		$233K Buy
68,401
+26,108
+62% +$147K ﹤0.01% 4213
2021
Q3 		$374K Buy
42,293
+1,380
+3% +$18.2K ﹤0.01% 3956
2021
Q2 		$694K Sell
40,913
-139,284
-77% -$2.04M ﹤0.01% 3615
2021
Q1 		$2.41M Buy
180,197
+109,533
+155% +$2.47M ﹤0.01% 2821
2020
Q4 		$2.04M Buy
70,664
+22,441
+47% +$607K ﹤0.01% 2835
2020
Q3 		$1.44M Buy
+48,223
New +$1.46M ﹤0.01% 2887

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon's AFIB Position: Q3 2022 in Review

Bank of New York Mellon sold out of Acutus Medical Inc (AFIB) in Q3 2022, closing a stake of 10,680 shares — an estimated $12K sold.

Bank of New York Mellon first reported a position in AFIB in Q3 2020 and held it in 8 quarters. The position peaked at $2.41M in Q1 2021. 37 funds tracked by Wall St. Rank hold AFIB as of Q3 2022.

  • Bank of New York Mellon reported no remaining Acutus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 10,680 Acutus Medical Inc shares in Q3 2022, an estimated $12K.
  • Bank of New York Mellon first reported a position in Acutus Medical Inc in Q3 2020 and held it in 8 quarters.
  • Bank of New York Mellon's Acutus Medical Inc position peaked at $2.41M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2022.

Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.